Clinical Trial Update: Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

The Phase 2 clinical trial evaluating Nitrocamptothecin for advanced small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED